While RSV is most often associated with infants—it's the leading cause of hospitalization in babies under six months—it also poses a serious risk to older adults. In fact, RSV can lead to severe complications like pneumonia and chronic respiratory disease in adults over 60, resulting in an estimated 100,000 and 150,000 hospitalizations annually.
However, doctors may have actually underestimated just how dangerous RSV can be for older adults. New research presented at the 2025 European Society of Clinical Microbiology and Infectious Diseases Global conference shows adults with RSV are 2.7 times more likely to die within a year than people without an RSV infection.
Between 2011 and 2022, researchers examined medical data from 5,289 adults diagnosed with RSV. After comparing their health outcomes to 15,867 people of similar age and stature who were not infected with RSV after one year, they concluded the following.
RSV resulted in more hospitalizations
People with RSV infection had to deal with more severe health problems over all, with hospitalization rates being more than double those without RSV infection (58% vs 28%). They also demonstrated four times higher admission to the intensive care unit (5.3% vs 1.4%).
Related: Who Actually Needs To Worry About RSV in the Coming Weeks
RSV increased the risk of complications from asthma and COPD
“Exacerbations of COPD and asthma were the most common adverse clinical outcomes. These pre-existing conditions are already challenging in themselves, and RSV-ARI exacerbates their severity," said Maria João Fonseca, Ph.D., an associate director of Global Real World Evidence and Health Outcomes, Vaccines for the pharmaceutical company GSK and the study's lead author. "Because of this, it’s crucial that we pay closer attention to patients with these underlying conditions to prevent further, potentially life-threatening complications.”
Related: The 6 Vaccines Doctors Are Begging Everyone Over 50 to Get
How to Protect Yourself From RSV
The Centers for Disease Control and Prevention currently recommends the RSV vaccine for anyone 75 and older. That said, anyone 60 or older who is considered high risk for complications is advised to get immunized as well. If you're unsure where you fall in terms of risk factors, ask your doctor or general practitioner.
Up Next:
Related: Doctors are Begging People 50+ to Get Vaccine Boosters of These Common Viruses
Sources
About RSV. Centers for Disease Control and Prevention.RSV in Older Adults. Centers for Disease Control and Prevention.Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections – a Danish nationwide cohort study. European Society of Clinical Microbiology and Infectious Diseases Global 2025.Maria João Fonseca, Ph.D., is an associate director of Global Real World Evidence and Health Outcomes, Vaccines for the pharmaceutical company GSK.Stanislava Bratković is a medical advisor for Vaccines at GSK. Read More Details
Finally We wish PressBee provided you with enough information of ( Having This Common Respiratory Condition Triples The Risk of Dying, Scientists Warn )
Also on site :